EUVIMEDOpdag EUVIMED
Crossref

Machine learning identified promising markers for cervical cancer prognosis and immune response from sphingolipid metabolism

Jun-Jie Zhu, Xiao-Hai Wang, Yu Liang, Wei Zhou, Chun-Ming Guo

New Medicine · 2025-03-10 · 3 (1) · 82-101

DOI: 10.61958/nmog9547 ↗

At a glance

Journal article in New Medicine, published online on 2025-03-10. Written by Jun-Jie Zhu and 4 co-authors. 61 references.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Cervical cancer (CC) poses a significant women's health challenge, with limited therapeutic efficacy for advanced cases. Recent studies suggest sphingolipid metabolism plays a critical role in tumor progression and immune regulation, offering potential prognostic markers and therapeutic targets.

Methods

We employed bioinformatics and machine learning approaches to analyze CC datasets from TCGA and GEO. Differentially expressed sphingolipid metabolism-related genes (DESMRGs) were identified, followed by LASSO regression and an optimized XGBoost algorithm to construct a prognostic model. Immune profiling, functional enrichment, and drug sensitivity analyses were performed to explore molecular mechanisms and therapeutic implications.

Results

Four key DESMRGs (DEGS2, LYN, CERS4, ALOX12B) were identified as prognostic markers, forming a robust model with high predictive accuracy (AUC: 0.906-0.948). The model stratified patients into high- and low-risk groups with significant survival differences. Functional enrichment revealed these genes' roles in lipid metabolism and immune modulation. Immune profiling indicated enhanced dendritic cell infiltration in the low-risk group, while high-risk patients showed elevated myocyte levels. Drug sensitivity analysis highlighted potential therapeutic agents tailored to risk groups.

Conclusions

This study developed a novel prognostic model based on sphingolipid metabolism-related genes, providing insights into CC biology and informing personalized treatment strategies.

Cite

APA

Zhu, J., Wang, X., Liang, Y., Zhou, W., & Guo, C. (2025). Machine learning identified promising markers for cervical cancer prognosis and immune response from sphingolipid metabolism. New Medicine, 3(1), 82-101. https://doi.org/10.61958/nmog9547

Vancouver

Zhu J, Wang X, Liang Y, Zhou W, Guo C. Machine learning identified promising markers for cervical cancer prognosis and immune response from sphingolipid metabolism. New Medicine. 2025;3(1):82-101. doi:10.61958/nmog9547

BibTeX
@article{Zhu2025,
  author = {Zhu, Jun-Jie and Wang, Xiao-Hai and Liang, Yu and Zhou, Wei and Guo, Chun-Ming},
  title = {Machine learning identified promising markers for cervical cancer prognosis and immune response from sphingolipid metabolism},
  journal = {New Medicine},
  year = {2025},
  volume = {3},
  number = {1},
  pages = {82--101},
  doi = {10.61958/nmog9547}
}
Start for free →